Switzerland
Lonza plans new pharmaceutical production site in the US
Basel-based Lonza plans to build a spray-drying production facility in Bend, Oregon, due to open in 2029 and create more than 80 jobs. The investment is designed to expand the company’s US pharmaceutical manufacturing capabilities.
AI10 settembre 2026

Article content structure is incomplete. Please refresh or contact support.